Gamma Knife Market Size & Growth Forecast 2027–2036, By Segments (Indication), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Jump to content
Market Size and Growth Outlook
Gamma Knife Market size was around USD 504.8 million in 2026 and is slated to grow at a 4.75% CAGR from 2027 to 2036, exceeding USD 802.9 million by 2036. The industry revenue for 2027 is calculated at USD 524.99 million.
Get more details on this report
Request Free Sample ReportGamma Knife Market Intelligence Snapshot
Regional Market Dynamics
- North America leads due to advanced neurosurgical centers, strong imaging infrastructure, established radiosurgery workflows, and consistent procedural adoption for complex neurological and tumor cases.
- Asia Pacific grows at 5.88% CAGR due to rising investment in specialized cancer and neurological care, expanding radiosurgery capacity, and growing adoption of non-invasive precision treatment systems.
Segment Momentum
- Malignant tumors held a 48.44% market share in 2026, supported by sustained demand for precise intracranial treatment approaches that help control lesions while minimizing damage to surrounding brain tissue.
- Benign tumors are growing fastest because clinicians increasingly favor highly targeted radiosurgery that preserves neurological function and reduces the procedural burden associated with open surgical interventions.
Market Expansion Drivers
- Rising prevalence of brain tumors increasing demand for precision radiosurgery treatments.
- Technological advancements in frameless gamma knife systems improving treatment precision and workflow efficiency.
- Expanding minimally invasive neurosurgery adoption strengthening hospital investments in advanced radiotherapy platforms.
Leading Market Participants
- Leading players in the gamma knife market include Elekta AB (Sweden), Siemens Healthineers AG (Germany), GE HealthCare Technologies Inc. (United States), Varian Medical Systems, Inc. (United States), Huiheng Medical, Inc. (China), Masep Medical Science & Technology Development Co., Ltd. (China), Accuray Incorporated (United States), Brainlab AG (Germany).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 504.8 million
- 2027 Estimated Market Size: USD 524.99 million.
- Projected Market Size: USD 802.9 million by 2036
- Growth Forecast: 4.75% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Malignant Tumors (Indication)
- Emerging Opportunity Segment: Benign Tumors (Indication)
Market Growth Drivers and Industry Trends
Rising prevalence of brain tumors increasing demand for precision radiosurgery treatments
The growing prevalence of brain tumors is driving the gamma knife market as patients and healthcare providers seek precise treatment approaches capable of targeting intracranial lesions while limiting exposure to surrounding healthy tissue. Gamma knife radiosurgery delivers focused radiation to defined targets and can be used for selected brain tumors and other intracranial conditions without conventional surgical intervention. The need for specialized treatment options that support tumor control with reduced surgical disruption is increasing interest in precision radiosurgery within neurosurgical care.
Technological advancements in frameless gamma knife systems improving treatment precision and workflow efficiency
Advancements in frameless gamma knife technology are strengthening the gamma knife market by improving treatment planning, patient positioning, and procedural flexibility. Frameless systems can reduce reliance on rigid fixation approaches and support more streamlined treatment workflows while maintaining accurate radiation delivery. Integration of advanced imaging, treatment planning software, and precision targeting capabilities can further help clinicians define treatment areas and optimize radiation delivery, improving the operational efficiency of facilities providing stereotactic radiosurgery.
Expanding minimally invasive neurosurgery adoption strengthening hospital investments in advanced radiotherapy platforms
Growing acceptance of minimally invasive neurosurgical approaches is supporting the gamma knife market as hospitals expand their capabilities for treatments that can reduce the physical burden associated with conventional surgery. Gamma knife systems provide a non-invasive radiosurgical option for selected intracranial conditions, allowing healthcare providers to address lesions without traditional surgical access to the brain. As hospitals seek to broaden specialized neurosurgical and radiotherapy services, investments in advanced stereotactic treatment platforms can support the development of dedicated precision treatment capabilities.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of brain tumors increasing demand for precision radiosurgery treatments | 2.00% | Moderate | North America, Europe, Asia Pacific | High | Near Term |
| Technological advancements in frameless gamma knife systems improving treatment precision and workflow efficiency | 1.80% | High | North America, Europe | High | Mid Term |
| Expanding minimally invasive neurosurgery adoption strengthening hospital investments in advanced radiotherapy platforms | 1.50% | Moderate | Asia Pacific, Latin America | Emerging | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held the largest share of the gamma knife market in 2026, supported by advanced healthcare infrastructure, widespread access to specialized neurosurgical facilities, and strong adoption of sophisticated radiation therapy technologies. The region’s established clinical expertise in non-invasive treatment of brain disorders, combined with investments in advanced medical equipment and precision treatment capabilities, supports demand for gamma knife systems. Growing preference for minimally invasive approaches and improvements in image-guided treatment are further reinforcing regional market strength.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is experiencing the fastest growth, driven by expanding healthcare infrastructure, increasing access to specialized neurological care, and rising adoption of advanced radiation-based treatment technologies. Growing awareness of minimally invasive treatment options and efforts to modernize hospitals are creating additional opportunities for gamma knife systems. Increasing healthcare investment and improving availability of specialized medical centers are also supporting broader adoption across major markets in the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation HubiScaleNascentDeveloping Advanced | |||||
| Cost-Sensitive RegioniScaleLowMedium High | |||||
| Regulatory EnvironmentiScaleRestrictiveNeutral Supportive | |||||
| Demand DriversiScaleWeakModerate Strong | |||||
| Development StageiScaleEmergingDeveloping Developed | |||||
| Adoption RateiScaleLowMedium High | |||||
| New Entrants / StartupsiScaleSparseModerate Dense | |||||
| Macro IndicatorsiScaleWeakStable Strong |
Key Country Insights
Germany 🇩🇪
Precision Radiosurgery ServicesGermany emphasizes Gamma Knife utilization within specialized neuroscience centers that focus on highly accurate intracranial treatment. German healthcare providers continue investing in advanced radiosurgery capabilities that improve clinical planning, patient outcomes, and multidisciplinary treatment coordination.
France 🇫🇷
Multidisciplinary Neuroscience FocusFrance strengthens Gamma Knife utilization through multidisciplinary clinical teams managing complex intracranial disorders. French hospitals emphasize precise treatment planning, technology modernization, and coordinated care that supports effective radiosurgical interventions for eligible patients.
Italy 🇮🇹
Hospital Technology RenewalItaly advances Gamma Knife adoption by upgrading neurosurgical treatment capabilities within specialized healthcare facilities. Italian providers prioritize modern radiosurgery platforms that improve procedural efficiency, support accurate treatment delivery, and enhance collaboration across neurological care teams.
Japan 🇯🇵
High-Accuracy Treatment PathwaysJapan applies Gamma Knife technology to support precise treatment of neurological conditions while minimizing invasive procedures. Japanese hospitals prioritize equipment reliability, advanced treatment planning, and efficient patient management within established neurosurgical care pathways.
South Korea 🇰🇷
Specialized Treatment ExpansionSouth Korea continues expanding access to Gamma Knife procedures through advanced tertiary hospitals and specialized neurological care centers. Healthcare providers focus on integrating precise radiosurgery with modern imaging technologies and coordinated patient treatment pathways.
United States 🇺🇸
Advanced Neurosurgical CareThe U.S. maintains demand for Gamma Knife systems through specialized neurosurgical centers treating complex brain disorders. Healthcare providers prioritize workflow efficiency, treatment precision, and integration with advanced imaging technologies to support minimally invasive neurological care.
Gamma Knife Market Share (%), by Indication, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportIndication Segment Analysis: Malignant Tumors (Largest Segment) vs Benign Tumors (Fastest-Growing Segment)
In the gamma knife market, the malignant tumors indication segment held the largest share of 48.44% in 2026, reflecting the established role of stereotactic radiosurgery in managing complex intracranial cancers. Gamma knife treatment enables highly focused radiation delivery while limiting exposure to surrounding healthy tissue, making it valuable for patients requiring precise treatment of difficult-to-access lesions. Growing emphasis on minimally invasive cancer treatment, improved imaging and treatment planning, and the need for alternatives to conventional surgical procedures continue to support adoption in malignant tumor care.
Benign tumors represent the fastest-growing indication segment, supported by increasing utilization of precision radiosurgery for intracranial lesions where preserving neurological function and minimizing surgical intervention are important treatment considerations. Gamma knife technology can provide targeted therapy without the need for conventional open surgery, making it attractive for selected patients with challenging tumor locations. Greater clinical awareness of stereotactic treatment options and continued advances in radiation targeting are expected to strengthen demand for gamma knife procedures in benign tumor management.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Indication | Malignant Tumors, Benign Tumors, Vascular Disorders, Functional Disorders, Ocular Diseases | Malignant Tumors | Benign Tumors |
Competitive Landscape and Market Positioning
Key companies in the gamma knife market:
1. Elekta AB (Sweden)
2. Siemens Healthineers AG (Germany)
3. GE HealthCare Technologies Inc. (United States)
4. Varian Medical Systems Inc. (United States)
5. Huiheng Medical Inc. (China)
6. Masep Medical Science & Technology Development Co. Ltd. (China)
7. Accuray Incorporated (United States)
8. Brainlab AG (Germany)
Technological progress in precision radiosurgery is shaping the competitive environment of the gamma knife market. Industry participants are introducing advanced treatment planning systems, improved imaging integration, and enhanced targeting capabilities to support more accurate neurological procedures. Expansion into emerging healthcare facilities and increasing emphasis on non-invasive treatment alternatives are also contributing to broader adoption and competitive differentiation within the market.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Elekta AB (Sweden) | |||||||
| Siemens Healthineers AG (Germany) | |||||||
| GE HealthCare Technologies Inc. (United States) | |||||||
| Varian Medical Systems Inc. (United States) | |||||||
| Huiheng Medical Inc. (China) | |||||||
| Masep Medical Science & Technology Development Co. Ltd. (China) | |||||||
| Accuray Incorporated (United States) | |||||||
| Brainlab AG (Germany). |
Industry Development / News
| Company Name | Date | Key Development |
|---|---|---|
| Health Sciences Centre Winnipeg | Mar-26 | The Health Sciences Centre Winnipeg integrated a next-generation Gamma Knife stereotactic radiosurgery system into its neurosurgical department. This deployment enhances the facility's capacity for minimally invasive brain treatments, directly expanding high-precision neurological care and radiosurgery capabilities within the Manitoba healthcare region. |
| Ram Manohar Lohia Institute of Medical Sciences | Oct-25 | The institute inaugurated the first Gamma Knife center in Uttar Pradesh, marking a significant expansion of non-invasive neurosurgical infrastructure. The facility provides specialized radiosurgery for complex brain tumors and neurological disorders, effectively increasing the regional availability of precision-targeted radiation therapy. |
| KIMS Hospital | May-25 | KIMS Hospital expanded its neuro-oncology service line by commissioning advanced Gamma Knife stereotactic radiosurgery capabilities. The move strengthens the hospital's position in the precision oncology market by offering a non-invasive treatment pathway for brain disorders, improving patient access to specialized neurological care. |
| Atrium Health | Jul-24 | Atrium Health recorded rapid clinical adoption of its Gamma Knife radiosurgery program, exceeding 100 procedures within five months of operational launch. This milestone validates the market demand for specialized stereotactic radiosurgery services and demonstrates the effective scaling of advanced neurosurgical technology within a large-scale hospital network. |
| Fortis Memorial Research Institute | Jun-24 | The institute launched South Asia’s first Gamma Knife Esprit system, upgrading its radiotherapy infrastructure for complex neurological and oncological interventions. This deployment represents a major advancement in regional radiosurgery capacity, enabling more precise, incision-free treatment for patients with brain-based pathologies. |
| AdventHealth Orlando | Jun-24 | AdventHealth Orlando completed the deployment of the Gamma Knife Elekta Esprit platform. This strategic technology integration enhances the center’s radiosurgery portfolio, allowing for more efficient treatment of intracranial tumors and neurological conditions through the application of advanced, incision-free radiation delivery technology. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Gamma Knife Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| End User | Hospitals, Specialty Neurosurgical Centers, Academic & Research Centers |
| Treatment Setting | Inpatient Facilities, Outpatient Facilities, Ambulatory Specialty Centers |
| System Generation | Legacy Gamma Knife Systems, Modern Fixed-Source Systems, Adaptive & Robotic Gamma Knife Systems |
Gamma Knife Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Radiosurgery Center Expansion Opportunity Assessment |
|
| Hospital Capital Equipment Procurement Landscape |
|
| Installed Base Modernization Assessment |
|
Need a different cut of the data?
Request Custom ResearchFrequently Asked Questions
How much is the gamma knife market worth?
How is the gamma knife industry expected to grow over the next 10 years?
How are frameless gamma knife innovations influencing hospital investment decisions?
Why is the shift toward minimally invasive neurosurgery supporting growth in the gamma knife market?
What makes malignant tumors the largest indication segment in the gamma knife market?
Why are benign tumors the fastest-growing indication for gamma knife treatment?
Why does North America lead the gamma knife market?
What is driving Asia Pacific’s growth in the gamma knife market?
What are the key competitors in the gamma knife landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Delivery
Published
Available
Support
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook